Survival analysis revealed that genes such as RPL36A, MRPL35, PDLIM7, and PCSK5 were predicting longer survival of GBM, while AP1S1, AKAP12, ALPL, SHC1, ERBB2, and MUC1 were predicting shorter survival of GBM. This evidence concerns the gene ERBB2 and glioblastoma.